Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Life Science Byrån LSB AB
AB
Active
Org 5568803414
Nya Valsätravägen 12, 756 46
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Life Science Byrån LSB AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 1M (-50% vs 2022)
1M
-50%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 1M
1M
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 735
1 575
1 450
1 507
1 495
Staff expenses
—
—
—
—
—
EBITDA
612
561
421
548
606
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
612
561
421
548
606
Net financials
6
15
11
—
—
Profit before tax
593
575
431
548
606
Tax
−125
−122
−91
−114
−126
Net profit
468
453
340
434
480
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 850
1 605
1 448
1 420
1 238
Equity
1 280
1 092
919
879
725
Long-term debt
0
0
0
0
0
Short-term debt
220
188
204
216
189
Total debt
220
188
204
216
189
Financial ratios
5-year trend
EBITDA margin
35,3 %
This company
15,8 %
Market median
This company
Market median
123% above market
2021
2025
Equity ratio
69,2 %
This company
38,2 %
Market median
This company
Market median
81% above market
2021
2025
Return on equity
36,6 %
This company
18,4 %
Market median
This company
Market median
99% above market
2021
2025
Net profit margin
27,0 %
This company
8,1 %
Market median
This company
Market median
233% above market
2021
2025
Asset turnover
0,94×
This company
1,12×
Market median
This company
Market median
16% below market
2021
2025
Debt / equity
0,45×
This company
0,62×
Market median
This company
Market median
27% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Life Science Byrån LSB AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
